Menu

Pharmaceutical Litigation

855-797-9899

Pharmaceutical Litigation

Complications
after taking
Benicar®?

If you suffered potentially
life-threatening gastrointestinal
problems as a result of taking
Benicar®, our Patient Advocates at
Pharma Suits can help.

Free Case Review




Vision Issues Caused by Benicar

Vision Loss and Eye Problems

Benicar is a frequently prescribed high blood pressure medication that has many serious side effects. The FDA has warned that the medication can cause damage to the intestines, chronic diarrhea, excessive weight loss, fetal toxicity, and allergic reactions, to name a few of the potential side effects associated with this drug. Vision problems are another side effect associated with Benicar and Benicar HCT.

Blurred vision side effects with Benicar (olmesartan medoxomil) have been reported by 256 people on eHealthMe. According to information directly from the manufacturer, Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) can cause acute myopia and glaucoma, and the possibility of permanent vision loss.

At Farah & Farah, we believe that people who are harmed by dangerous drugs should not have to suffer in silence. If you have experienced vision problems or other serious health consequences from taking Benicar, you may be entitled to file a claim for compensation. Call us to speak with a knowledgeable product liability attorney. We can tell you if you have a case and what damages you may be entitled to seek in your claim for compensation.

Blurred Vision with Benicar

As of March 14, 2016, 12,933 people had reported side effects with Benicar (olmesartan medoxomil) on healthcare data platform eHealthMe. Among the people reporting adverse effects, 256 suffer from blurred vision. Individuals with these symptoms had been taking the drug:

  • Less than a month: 25%
  • 1 to 6 months: 0%
  • 6 to 12 months: 25%
  • 1 to 2 years: 8.33%
  • 2 to 5 years: 33.33%
  • 5 to 10 years: 8.33%
  • 10+ years: 0%

Ages of the people who experienced blurred vision on Benicar were:

  • 30 to 39: 4.19%
  • 40 to 49: 9.30%
  • 50 to 59: 29.30%
  • 60+: 57.21%

Of the individuals reporting blurred vision with Benicar, 71.32% were female and 28.68% were male. The severity of the blurred vision was reported to be moderate in 50% and severe in 50% of these individuals. Patients who have suffered blurred vision or other eye damage need to connect with a law firm that focuses its work upon seeking justice in cases against Big Pharma.

Benicar HCT Can Cause Myopia and Glaucoma

According to safety information provided on the official company website, Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) can cause two separate serious health conditions affecting the eyes and vision:

  • Acute Myopia: With this adverse reaction, the victim becomes extremely nearsighted – unable to see objects clearly at a distance.
  • Secondary Angle-Closure Glaucoma: Glaucoma is an eye disease that can damage the optic nerve and lead to blindness. Angle closure refers to the way the eye pressure rises with the disease. Glaucoma caused by Benicar HCT is secondary to another condition.

When patients experience symptoms of either of the above conditions, Benicar HCT should be discontinued as soon as possible. Symptoms can occur within hours or weeks from starting the medication. These serious side effects can lead to permanent loss of vision.

Serious Health Consequences with Benicar

The FDA has issued safety warnings about a number of serious adverse reactions and side effects associated with Benicar. This drug was approved for treatment of hypertension by FDA on April 5, 2002. Unfortunately, FDA warnings and precautions and reports of post-marketing experience adverse reactions were not issued until:

  • May 2011: Anaphylactic reactions
  • February 2012: Avoid use in pregnancy; Morbidity in infants
  • March 2012: Fetal toxicity
  • July 2013: Spruelike enteropathy (severe intestinal disorder)
  • June 2014: Cardiovascular risk in diabetic patients

Benicar HCT was FDA approved for treatment of hypertension on June 5, 2003, but safety warnings regarding acute myopia and secondary angle-closure glaucoma were not issued until May 2011.

Doctors may have prescribed Benicar before the FDA warnings, and many patients may have lived with debilitating symptoms – or in some cases, symptoms that required repeated hospitalizations – for years.

Holding Drug Companies Accountable

Drug manufacturers have a duty under the law to warn patients and doctors of all potential side effects of the drugs they release on the market. Benicar was heavily prescribed for years without safety warnings about the associated dangerous side effects.

If you have suffered serious vision or health problems and were prescribed Benicar, you may be entitled to seek justice and pursue compensation in a product liability claim against the manufacturer of Benicar, Daiichi-Sankyo. It is in your best interests to consult with a knowledgeable product liability lawyer about your case.

At Farah & Farah, pharmaceutical litigation is what we do. Our practice is devoted to representing people who have been injured by dangerous drugs and devices. Our Benicar injury attorneys are currently investigating cases of people injured by dangerous drug cases nationwide. Call us at (800) 533-3555 for a free case evaluation.


Need help now? Speak with a
Patient Advocate now:
855-797-9899

Who We Are

The pharmaceutical litigation attorneys at Farah & Farah go after negligent corporations that put unsuspecting consumers in harm's way. Pharmaceutical companies not only have a duty to manufacture drugs that are safe, but they also have the obligation to warn consumers regarding dangerous side effects that can be caused by these drugs.

Learn More